Diagnostic Tests: Osmotic Fragility Test​

Overview

The osmotic fragility test is a diagnostic laboratory test used primarily in hematology to identify red blood cell (RBC) membrane defects. It is most famously associated with hereditary spherocytosis, a condition in which RBCs lose membrane surface area and become spherical in shape. Because of their altered structure, these cells are more susceptible to destruction when exposed to certain osmotic conditions. The test helps clinicians confirm the diagnosis in patients presenting with hemolytic anemia and characteristic findings on peripheral smear.


How the Test Works

The osmotic fragility test evaluates how easily RBCs lyse when placed in hypotonic (dilute) saline solutions. Normal red cells have a biconcave shape, giving them a high surface area-to-volume ratio and allowing them to tolerate changes in osmotic pressure. In contrast, spherocytes—such as those seen in hereditary spherocytosis—have reduced membrane surface area, making them less flexible and less able to expand when water enters the cell.


When placed in increasingly hypotonic solutions, spherocytes absorb water more rapidly and lyse at higher saline concentrations than normal cells. The degree of hemolysis is measured by the amount of hemoglobin released into the solution. A higher-than-normal level of hemolysis at moderate hypotonicity indicates increased osmotic fragility.


When Osmotic Fragility Is the Best Answer

You should choose osmotic fragility testing when evaluating a patient with features suggestive of hereditary spherocytosis, particularly when the case includes:

• Hemolytic anemia, often chronic or recurrent
• Splenomegaly
• Spherocytes on peripheral blood smear
• Family history of similar episodes
• Pigmented (bilirubin) gallstones, which develop from chronic hemolysis

These key clinical clues, combined with laboratory findings, strongly support the use of osmotic fragility testing as part of the diagnostic work-up.